{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:45:36Z","timestamp":1792215936721,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","award":["P30-CA008748"],"award-info":[{"award-number":["P30-CA008748"]}],"id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clbc.2026.08.005","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:26:14Z","timestamp":1786577174000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraoperative and Perioperative Outcomes of Breast-Conserving Surgery After Neoadjuvant Systemic Therapy: A Retrospective Cohort Study"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2120-2620","authenticated-orcid":false,"given":"Yashasvini","family":"Sampathkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-1877","authenticated-orcid":false,"given":"Tiana Y.","family":"Sepahpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanae K.","family":"Tokita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoushka","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1525-6503","authenticated-orcid":false,"given":"Andrew","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Assel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mamtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1834-7331","authenticated-orcid":false,"given":"Jennifer R.","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clbc.2026.08.005_bib0001","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa2406070","article-title":"Survival with Trastuzumab Emtansine in residual HER2-positive breast cancer","volume":"392","author":"Geyer","year":"2025","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.clbc.2026.08.005_bib0002","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.clbc.2026.08.005_bib0003","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.005_bib0004","doi-asserted-by":"crossref","first-page":"732e","DOI":"10.1097\/PRS.0000000000006112","article-title":"Outcomes in patients receiving neoadjuvant chemotherapy undergoing immediate breast reconstruction: effect of timing, postoperative complications, and delay to radiation therapy","volume":"144","author":"Teotia","year":"2019","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.005_bib0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/SLA.0000000000001804","article-title":"Surgical outcomes for mastectomy patients receiving neoadjuvant chemotherapy: a propensity-matched analysis","volume":"265","author":"Bowen","year":"2017","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1245\/s10434-020-08593-5","article-title":"How often does modern neoadjuvant chemotherapy downstage patients to breast-conserving surgery?","volume":"28","author":"Petruolo","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.005_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-016-4006-6","article-title":"Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance)","volume":"160","author":"Golshan","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.clbc.2026.08.005_bib0008","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1245\/s10434-016-5246-8","article-title":"How often does neoadjuvant chemotherapy avoid axillary dissection in patients with histologically confirmed nodal metastases? Results of a prospective study","volume":"23","author":"Mamtani","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0009","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12957-023-03199-z","article-title":"Neoadjuvant chemotherapy for stage II-III breast cancer: a single-center experience","volume":"21","author":"Zaher","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.005_bib0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1245\/s10434-019-08038-8","article-title":"Contralateral prophylactic mastectomy use after neoadjuvant chemotherapy","volume":"27","author":"Christian","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.005_bib0011","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1245\/s10434-016-5741-y","article-title":"Do calcifications seen on mammography after neoadjuvant chemotherapy for breast cancer always need to Be excised?","volume":"24","author":"Feliciano","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2026.08.005_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.21037\/tbcr-23-50","article-title":"Breast surgery after neoadjuvant systemic therapy","volume":"5","author":"Pawloski","year":"2024","journal-title":"Transl Breast Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0013","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s40164-025-00667-y","article-title":"Immunotherapy in breast cancer: current landscape and emerging trends","volume":"14","author":"Ran","year":"2025","journal-title":"Exp Hematol Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0014","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1200\/OP.22.00483","article-title":"Role of immunotherapy in breast cancer","volume":"19","author":"Jacob","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-023-01850-7","article-title":"Advances in immunotherapy for triple-negative breast cancer","volume":"22","author":"Liu","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clbc.2026.08.005_bib0016","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/ITT.S495751","article-title":"Recent advances in immune checkpoint inhibitors for triple-negative breast cancer","volume":"14","author":"Corti","year":"2025","journal-title":"Immunotargets Ther"},{"issue":"S2","key":"10.1016\/j.clbc.2026.08.005_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/anae.16522","article-title":"Systemic anti-cancer therapy and anaesthesia: a narrative review","volume":"80","author":"Weaver","year":"2025","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0018","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1213\/ANE.0000000000007210","article-title":"Novel cancer Therapeutics: perioperative implications and challenges","volume":"140","author":"Gutierrez","year":"2025","journal-title":"Anesth Analg"},{"key":"10.1016\/j.clbc.2026.08.005_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjao.2022.100119","article-title":"Effect of neoadjuvant chemotherapy on intraoperative core temperature in patients with breast cancer: a retrospective cohort study","volume":"5","author":"Kim","year":"2023","journal-title":"BJA Open"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.005_bib0020","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3988\/jcn.2024.0221","article-title":"Cardiovascular autonomic dysfunction before and after chemotherapy in cancer patients","volume":"20","author":"Yoon","year":"2024","journal-title":"J Clin Neurol"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.005_bib0021","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1634\/theoncologist.2018-0049","article-title":"A longitudinal study of the association of clinical indices of cardiovascular autonomic function with breast cancer treatment and exercise training","volume":"24","author":"Kirkham","year":"2019","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0022","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1152\/japplphysiol.00005.2018","article-title":"Vascular and autonomic changes in adult cancer patients receiving anticancer chemotherapy","volume":"125","author":"Frye","year":"2018","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.clbc.2026.08.005_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112503","article-title":"Clinical implications of chemotherapeutic agent organ toxicity on perioperative care","volume":"146","author":"Zeien","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0024","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jatmed.2024.11.003","article-title":"Neoadjuvant chemotherapy and perioperative cardiotoxicity","volume":"3","author":"Tu","year":"2024","journal-title":"J Anesth Transl Med"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1470-2045(23)00524-7","article-title":"Treatment-related adverse events, including fatal toxicities, in patients with solid tumours receiving neoadjuvant and adjuvant immune checkpoint blockade: a systematic review and meta-analysis of randomised controlled trials","volume":"25","author":"Fujiwara","year":"2024","journal-title":"Lancet Oncol"},{"issue":"16_suppl","key":"10.1016\/j.clbc.2026.08.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.e14621","article-title":"Adverse events and tolerability of immune checkpoint inhibitors (ICI) for the treatment of early stage of breast cancer (BC): a systematic review and meta analysis","volume":"43","author":"Dacoregio","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.005_bib0027","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bja.2019.11.034","article-title":"Immune checkpoint inhibitors: a narrative review of considerations for the anaesthesiologist","volume":"124","author":"Lewis","year":"2020","journal-title":"Br J Anaesth"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0028","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11912-022-01202-6","article-title":"Cancer immunotherapies: what the perioperative physician needs to know","volume":"24","author":"Ackerman","year":"2022","journal-title":"Curr Oncol Rep"},{"issue":"10","key":"10.1016\/j.clbc.2026.08.005_bib0029","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1530\/EC-20-0342","article-title":"Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review","volume":"9","author":"Stelmachowska-Bana\u015b","year":"2020","journal-title":"Endocr Connect"},{"key":"10.1016\/j.clbc.2026.08.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241257874","article-title":"Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trials","volume":"16","author":"Zhou","year":"2024","journal-title":"Ther Adv Med Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2026.08.005_bib0031","doi-asserted-by":"crossref","first-page":"5180","DOI":"10.1245\/s10434-024-15359-w","article-title":"Impact of neoadjuvant chemoimmunotherapy on surgical outcomes and time to radiation in triple-negative breast cancer","volume":"31","author":"Myers","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.005_bib0032","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1634\/theoncologist.6-2-162","article-title":"Hepatotoxicity of chemotherapy","volume":"6","author":"King","year":"2001","journal-title":"Oncologist"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.005_bib0033","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clbc.2025.03.004","article-title":"Perioperative considerations of breast cancer neoadjuvant treatments","volume":"25","author":"Brumer","year":"2025","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2026.08.005_bib0034","first-page":"199","article-title":"Approaching neoadjuvant therapy in the management of early-stage breast cancer","volume":"13","author":"Hyder","year":"2021","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejso.2021.09.007","article-title":"Impact of neoadjuvant chemotherapy on surgical complications in breast cancer: a systematic review and meta-analysis","volume":"48","author":"Lorentzen","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2026.08.005_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110511","article-title":"Impact of neoadjuvant immunotherapy on postoperative complications in oncoplastic breast cancer surgery","volume":"51","author":"Barjot","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.005_bib0037","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1213\/ANE.0000000000005356","article-title":"Enhanced recovery programs in an ambulatory surgical oncology center","volume":"133","author":"Afonso","year":"2021","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.005_bib0038","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jopan.2021.04.004","article-title":"Symptoms, surgical events, and length of stay of surgical oncology outpatients","volume":"37","author":"Bloom","year":"2022","journal-title":"J Perianesthesia Nurs"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0039","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1213\/ANE.0000000000003992","article-title":"Assessing rapidity of recovery after cancer surgeries in a single overnight short-stay setting","volume":"129","author":"Assel","year":"2019","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bjae.2021.08.002","article-title":"Anaesthesia after neoadjuvant chemotherapy, immunotherapy or radiotherapy","volume":"22","author":"Groenewold","year":"2022","journal-title":"BJA Educ"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0041","first-page":"504","article-title":"Median effective effect-site concentration of intravenous anesthetics for loss of consciousness in neoadjuvant chemotherapy patients","volume":"124","author":"He","year":"2011","journal-title":"Chin Med J"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.005_bib0042","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-022-06811-0","article-title":"The impact of neoadjuvant systemic treatment on postoperative complications in breast cancer surgery","volume":"197","author":"Nussbaumer","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0043","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21147\/j.issn.1000-9604.2020.01.05","article-title":"Effects of neoadjuvant chemotherapy on respiratory function in patients with breast cancer","volume":"32","author":"Ding","year":"2020","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"10.1016\/j.clbc.2026.08.005_bib0044","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jopan.2017.03.004","article-title":"Use of simulation software in optimizing PACU operations and promoting evidence-based practice guidelines","volume":"33","author":"Criddle","year":"2018","journal-title":"J Perianesthesia Nurs"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10916-023-01966-9","article-title":"Machine learning prediction models to reduce length of stay at ambulatory surgery centers through case resequencing","volume":"47","author":"Tully","year":"2023","journal-title":"J Med Syst"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.005_bib0046","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1080\/20479700.2020.1720940","article-title":"Determining future capacity for an Ambulatory Surgical Center with discrete event simulation","volume":"14","author":"Reece","year":"2021","journal-title":"Int J Healthc Manage"},{"issue":"51","key":"10.1016\/j.clbc.2026.08.005_bib0047","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013776","article-title":"Effects of neoadjuvant chemotherapy on the depth of total intravenous anesthesia in patients with breast cancer undergoing unilateral modified radical mastectomy: a prospective observational study","volume":"97","author":"Wu","year":"2018","journal-title":"Medicine"},{"issue":"1","key":"10.1016\/j.clbc.2026.08.005_bib0048","doi-asserted-by":"crossref","first-page":"29","DOI":"10.17085\/apm.22201","article-title":"Effect of neoadjuvant chemotherapy on effect-site concentration of propofol for sedation in patients with breast cancer","volume":"18","author":"Kim","year":"2023","journal-title":"Anesth Pain Med (Seoul)"},{"issue":"2","key":"10.1016\/j.clbc.2026.08.005_bib0049","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4097\/kja.21327","article-title":"Effect of chemotherapy on effect-site concentration of propofol for loss of consciousness in patients with colorectal cancer","volume":"75","author":"Ki","year":"2022","journal-title":"Korean J Anesthesiol"},{"issue":"7","key":"10.1016\/j.clbc.2026.08.005_bib0050","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/j.ejso.2021.01.025","article-title":"Optimal timing of surgery following breast cancer neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"47","author":"Cullinane","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.005_bib0051","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.amjsurg.2020.02.061","article-title":"Surgical timing following neoadjuvant chemotherapy for breast cancer affects postoperative complication rates","volume":"219","author":"Sutton","year":"2020","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.clbc.2026.08.005_bib0052","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.cllc.2023.08.017","article-title":"Impact of neoadjuvant immune checkpoint inhibitors on surgery and perioperative complications in patients with non\u2013small-cell lung cancer: a systematic review","volume":"24","author":"Takada","year":"2023","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2026.08.005_bib0053","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.semtcvs.2020.12.012","article-title":"Systematic review of neoadjuvant immunotherapy for patients with non\u2013small cell lung cancer","volume":"33","author":"Cao","year":"2021","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.clbc.2026.08.005_bib0054","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1308\/rcsann.2016.0135","article-title":"The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma","volume":"98","author":"Sinclair","year":"2016","journal-title":"Ann R Coll Surg Engl"},{"issue":"5","key":"10.1016\/j.clbc.2026.08.005_bib0055","doi-asserted-by":"crossref","first-page":"358","DOI":"10.5152\/TJAR.2022.21158","article-title":"Cardiopulmonary exercise testing as a predictor of postoperative outcome in patients undergoing oesophageal cancer surgery following neoadjuvant chemotherapy","volume":"50","author":"Suri","year":"2022","journal-title":"Turk J Anaesthesiol Reanim"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:31:37Z","timestamp":1792215097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1526820926001436"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraoperative and Perioperative Outcomes of Breast-Conserving Surgery After Neoadjuvant Systemic Therapy: A Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}